Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery, Based on Guideline Updates: A Mini Review
Publish place: Journal of Health Reports and Technology، Vol: 8، Issue: 3
Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 152
This Paper With 6 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJHLS-8-3_003
تاریخ نمایه سازی: 28 تیر 1402
Abstract:
Nonalcoholic fatty liver disease (NAFLD) refers to fat accumulation in hepatic cells due to alcohol consumption, hepatitis, and drugs.
The prevalence of this disease has been reported at ۲۰-۵۰% in western and۱۲ - ۱۳% in Latin countries. Patientswhosuffer from obesity,
diabetes, and insulin resistance may be affected more than others. This disease is symptomless, and its paraclinical diagnosis is
achievable by increasing the hepatic enzymes. Ultrasonography and fibroscan are some of thecommondiagnostic methods for this
disease. The first treatment for this disease is weight loss and physical activities. Vitamin E can improve histopathological changes
in terms of medications. While pioglitazone is an effective blood sugar-lowering drug, metformin has no role in treating diabetes
or prediabetes.
Keywords:
Authors
Mohsen Arabi
Preventive Medicine and Public Health Research Center, Family Medicine Department, Iran University of Medical Sciences, Tehran, Iran
Raheleh Alimoradzadeh
Firoozabadi Clinical Research Development Unit (FACRDU), University of Medical Sciences (IUMS), Tehran, Iran
Alireza Makian
Firoozabadi Clinical Research Development Unit (FACRDU), University of Medical Sciences (IUMS), Tehran, Iran
Seyed Javad Shariat Nabavi
Isfahan AL-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran